Horizon Bancorp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
51
﹤0.01% 209
2025
Q4
$0 Hold
51
﹤0.01% 192
2025
Q3
$1K Hold
51
﹤0.01% 181
2025
Q2
$1K Hold
51
﹤0.01% 203
2025
Q1
$1K Sell
51
-1,600
-97% -$24.6K ﹤0.01% 171
2024
Q4
$25K Buy
1,651
+1,585
+2,402% +$25.8K 0.01% 138
2024
Q3
$1K Sell
66
-41
-38% -$850 ﹤0.01% 216
2024
Q2
$2K Sell
107
-53
-33% -$1.05K ﹤0.01% 212
2024
Q1
$3K Hold
160
﹤0.01% 219
2023
Q4
$2K Hold
160
﹤0.01% 227
2023
Q3
$3K Sell
160
-13
-8% -$271 ﹤0.01% 222
2023
Q2
$4K Buy
173
+130
+302% +$2.83K ﹤0.01% 213
2023
Q1
$1K Hold
43
﹤0.01% 175
2022
Q4
$1K Buy
+43
New +$1.1K ﹤0.01% 203

Other funds holding OGN

Horizon Bancorp's OGN Position: Q1 2026 in Review

Horizon Bancorp held its Organon & Co (OGN) position steady in Q1 2026 at 51 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #209.

Horizon Bancorp first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $25K in Q4 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Horizon Bancorp held 51 shares of Organon & Co worth $0 as of Q1 2026.
  • Horizon Bancorp left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Horizon Bancorp's portfolio in Q1 2026, its #209 holding.
  • Horizon Bancorp first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Horizon Bancorp's Organon & Co position peaked at $25K in Q4 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.